Skip to content

Extended Fragrance Ingredients Surveillance Study

Extended Fragrance Ingredients Surveillance Study - EFISS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00033263
Enrollment
8100
Registered
2024-09-16
Start date
2025-01-02
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L23.5

Interventions

Group 1: Consecutive patients patch tested for suspected contact allergy

Sponsors

The International Fragrance Association (IFRA)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Indication for patch testing according to ESCD guideline

Exclusion criteria

Exclusion criteria: No study specific exclusion criteria beyond those exclusions in accorance with patch test gideline

Design outcomes

Primary

MeasureTime frame
Contact allergy to one of the 7 audit fragrance substances

Secondary

MeasureTime frame
(i) gender- and age-stratified results; (ii) geographically/department-wise stratified results; (iii) time trend analyses, as far as feasible; (iv) co-reactivity between audit substances and other fragrances, respectively, (v) clinical relevance assessment of the audit substances, (vi) patch test reaction pattern, (vii) quality control results.

Countries

Croatia, Greece, Ireland, Italy, Netherlands, Portugal, Sweden, Switzerland

Contacts

Public ContactWolfgang Uter

Institut für Medizininformatik, Biometrie und Epidemiologie, Univ. Erlangen/Nürnberg

wolfgang.uter@fau.de+4991318522720

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026